Author: OurCrowd

[Clinch in PR Newswire] Clinch expands collaboration with Amazon Ads, announcing support for automated creative trafficking with Amazon DSP

NEW YORK, June 4, 2026 /PRNewswire/ — Clinch, the agentic AI platform for omnichannel content orchestration, today announced an expanded integration with Amazon DSP. Building on its global certification with Amazon Ads, Clinch is now one of the initial third-party ad serving providers to deliver a fully automated, omnichannel workflow that connects creative development directly to media execution across streaming TV, online video, display and mobile channels. The integration enables a two-way sync between Flight Control and Amazon DSP, allowing campaign data to flow instantly while automatically publishing and assigning creative tags to media placements, reducing operational friction. Read more...

Read More

[Classiq in Globe Newswire] Classiq and UC Chile launch quantum AI research for biomedical image analysis leveraging integration with NVIDIA CUDA-Q

SANTIAGO, Chile, and BOSTON, June 04, 2026 (GLOBE NEWSWIRE) — Classiq and Pontificia Universidad Católica de Chile (UC Chile) today announced a joint research project to develop hybrid quantum algorithms for biomedical image analysis, assisted by classical machine learning and the NVIDIA CUDA-Q platform for quantum-classical computing. Read More...

Read More

[Dandelion Energy in PR Newswire] Dandelion Energy partners with Woodland Peak Development to bring geothermal heating and cooling to Massachusetts townhome community

BELLINGHAM, Mass., June 3, 2026 /PRNewswire/ — Dandelion Energy, the nation’s leading provider of residential geothermal heating and cooling, today announced a partnership with Woodland Peak Development to bring geothermal systems to Whitman Acres, a new 15-unit all-electric townhome community in Bellingham, Massachusetts. The project marks another step in Dandelion’s mission to make geothermal the default heating and cooling solution for new homes that works for builders’ budgets and delivers outsized value to homebuyers. Read...

Read More

[Alpha Tau in Globes] Alpha Tau teams with Tolmar on lucrative prostate cancer deal

Israeli innovative cancer radiation treatment company Alpha Tau Medical (Nasdaq: DRTS) today announced a strategic collaboration agreement with Tolmar International to develop and commercialize Alpha DaRT for the treatment of prostate cancer in the US. Alpha Tau’s share price has risen 85% since the start of 2026, and 198% over the past year, giving a market cap of $807 million. The company’s share price opened 22% higher today on Wall Street, giving a market cap of $984.5 million. Read...

Read More